Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 6

Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn's disease

Pages
568–569
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

HEATH, R. D., TAHAN, V. (2022). Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn's disease. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 6, 568–569. https://ajindex.com/articles/606484

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Başaranoğlu M, Sayılır A, Yüksel M, et al. Characterization of de novo colonic stricture due to Crohn's disease. Turk J Gastroen- terol. 2014; 25(Suppl 1): 129-32. [CrossRef] Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease? A population based study. Clin Gastroenterol Hepatol 2006; 4: 1130-4. [CrossRef] Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn's disease in a population based cohort. Dis Colon Rectum 2012; 55: 773-7. [CrossRef] Ingle SB, Loftus EV Jr. The natural history of perianal Crohn's dis- ease. Dig Liver Dis 2007; 39: 963-9. [CrossRef] Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn's dis- ease fistula. Inflamm Bowel Dis 2014; 20: 2022-8. [CrossRef] Cat H, Sophani I, Lemann M, Modiglani R, Solue JC. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease. Turk J Gastroenterol 2003; 14: 121-7.
  2. Duijvestein M, Vos AC, Roelofs H, et al. Autologous bone marrow derived mesenchymal stromal cell treatment for refractory lumi- nal Crohn's disease: results of a phase I study. Gut 2010: 59: 1662- 19. [CrossRef] Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 2011; 60: 788-98. [CrossRef] Molendijk I, Bonsing BA, Roelofs H, et al. Allogeneic Bone Marrow- Derived Mesenchymal Stromal Cells Promote Healing of Refrac- tory Perianal Fistulas in Patients With Crohn's Disease. Gastroen- terology 2015; 149: 918-27. [CrossRef] Panés J, García-Olmo D, Van Assche G, et al; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016 Jul 28. pii: S0140-6736(16)31203-X. doi: 10.1016/ S0140-6736(16)31203-X. [Epub ahead of print] [CrossRef] Tahan AC, Tahan V. "If a fake friend stays in your vocabulary as a stem friend": granulocyte colony-stimulating factor promoted stem cell therapy in severe alcoholic hepatitis. Turk J Gastroen- terol 2014; 25: 748-9. [CrossRef] 569